A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
The Netherlands- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to the Netherlands48 clinical trials in Geleen, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
The NetherlandsOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
The NetherlandsA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
The NetherlandsAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
The NetherlandsRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
The NetherlandsRituximab and venetoclax treatment for 6 vs 26 cycles in patients with relapsed or refractory chronic lymphocytic leukemia
The NetherlandsA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
The NetherlandsA Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer
The NetherlandsStudy of daratumumab, teclistamab and talquetamab combination treatment for frail patients with newly diagnosed multiple myeloma
The NetherlandsStudy on Letrozole and Gonadotropins for Women with Polycystic Ovary Syndrome (PCOS) to Improve Live Birth Rates
The NetherlandsStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
The NetherlandsStudy on [18F]-AlF-FAPI-74 for Staging Advanced Stomach Cancer in Patients Using PET/CT and Laparoscopy
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials exploring treatments for various cancer types, including gastric cancer, breast cancer, and lung cancer. Studies focus on innovative therapies and diagnostic approaches.
Multiple trials investigating personalized treatment approaches and immunotherapy options.
Comprehensive research into inflammatory bowel conditions, with particular focus on Crohn's Disease and Ulcerative Colitis. Studies evaluating long-term treatment effectiveness.
Emphasis on developing sustainable treatment options for chronic conditions.
Advanced research into Multiple Sclerosis treatment and management. Trials focusing on long-term safety and efficacy of innovative therapies.
Investigation of treatment effectiveness in various MS disease courses.
Tell us about your condition – we search every trial in Europe and connect you with the right site.